Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia

International Journal of Clinical Practice

Volumn 59, Issue 3, 2005, Pages 311-317

  Kolovou, Genovefa D ^a   Anagnostopoulou, K K ^a   Pilatis, N D ^a   Iraklianou, S ^b   Hoursalas, I S ^a   Liberi, S ^c   Pavlidis, A N ^a   Dritsas, A ^a   Mikhailidis, D P ^d   Cokkinos, D V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c Sotiria University Hospital   (Greece)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chylomicrons; Coronary heart disease; Familial hypercholesterolaemia; Low density lipoprotein receptors; Post prandial hypertriglyceridaemia

Indexed keywords

ACETYLSALICYLIC ACID; ISOSORBIDE MONONITRATE; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ETHNOLOGY; EVIDENCE BASED MEDICINE; FAMILIAL HYPERCHOLESTEROLEMIA; GREECE; HETEROZYGOSITY; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID DIET; MALE; METABOLIC DISORDER; NORMAL VALUE; POSTPRANDIAL STATE; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TIME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 20044394352     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2004.00223.x     Document Type: Article

References (52)

1. Hopkins PN. Familial hypercholesterolemia-Improving treatment and meeting guidelines. Int J Cardiol 2003; 89: 13-23.
2. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445-66.
3. Ose L. An update on familial hypercholesterolaemia. Ann Med 1999; 31: 13-8.
4. Kolovou G, Daskalova D, Mastorakou I, Anagnostopoulou K, Cokkinos DV. Regression of Achilles tendon xanthomas evaluated by CT scan after hypolipidemic treatment with simvastatin. Angiology 2004; 55: 335-9.
5. Ballantyne CM. Familial hypercholesterolaemia: optimum treatment strategies. Int J Clin Pract Suppl 2002; 130: 22-6.
6. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. USA: McGraw-Hill Information Service Company, 1995: 1981-2030.
7. Raal FJ, Pilcher GJ, Waisberg R, Buthelezi EP, Veller MG, Joffe BI. Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia. Am J Cardiol 1999; 83: 1330-3.
8. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-85.
9. Boquist S, Ruotolo G, Tang R et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common intima-media thickness in healthy, middle-aged men. Circulation 1999; 100: 723-8.
10. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
11. Uiterwaal CS, Grobbee DE, Witteman JC et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 1994; 121: 576-83.
12. Malloy MJ, Kane JP. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 2001; 47: 111-36.
13. Weintraub MS, Grosskopf I, Rassin T et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 1996; 312: 936-9.
14. Meyer E, Westerveld HT, de Ruyter-Meijstek FC et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis 1996; 124: 221-35.
15. Tan KC, Cooper MB, Ling KL et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 1995; 113: 273-87.
16. Chapman JM, Guerin M, Bruckert E. Role of anomalies of low density lipoproteins (LDL) in atherogenicity. Bull Acad Natl Med 2001; 185: 35-9.
17. Kolovou GD, Daskalova CD, Iraklianou SA et al. Postprandial lipemia in hypertension. J Am Coll Nutr 2003; 22: 80-7.
18. Patsch JR, Miesenbock G, Hopferwieser T et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-45.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Programme (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
21. Eriksson JW, Buren J, Svensson M, Olivecrona T, Olivecrona G. Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis 2003; 166: 359-67.
22. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; 129: 79-88.
23. Weintraub MS, Eisenberg S, Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. J Clin Invest 1987; 79 1110-9.
24. Cabezas MC, de Bruin TW, Westerveld HE, Meijer E, Erkelens DW. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia. J Int Med 1998; 244: 299-307.
25. Le NA, Coates PM, Gallagher PR, Cortner JA. Kinetics of retinyl esters during postprandial lipemia in man: a compartmental model. Metabolism 1997; 46: 584-94.
26. Mamo JC, Smith D, Yu KC, Kawaguchi A, Harada-Shiba M, Yamamura T, Yamamoto A. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia. Eur J Clin Invest 1998; 28: 379-84.
27. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochem Biophys Acta 1983; 737: 197-222.
28. Watts GF, Barrett PH, Matais AD et al. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test. Atherosclerosis 2001; 157: 519-23.
29. Rubinsztein DC, Cohen JC, Berger GM, van der Westhuyzen DR, Coetzee GA, Gevers W. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest 1990; 86: 1306-12.
30. Ooi TC, Cousins M, Ooi DS et al. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab 2001; 86: 3134-42.
31. Ordovas JM. Genetics, postprandial lipemia and obesity. Nutr Metab Cardiovasc Dis 2001; 11: 118-33.
32. Levy E, Menard D, Delvin E et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 2001; 276: 39679-84.
33. Kolovou G, Daskalova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiolog 2003; 54: 59-71.
34. Oliver MF, Davies MJ. The atheromatous lipid core. Eur Heart J 1998; 19: 16-8.
35. University College London Medical School. Hypertriglyceridaemia and vascular risk. Report of a meeting of physicians and scientists. Lancet 1993; 342: 781-7.
36. Funada J, Sekiya M, Hamada M, Hiwada K. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction. Circ J 2002; 66: 127-32.
37. Jagla A, Schrezenmeir J. Postprandial triglycerides and endothelial function. Exp Clin Endocrinol Diab 2001; 109: S533-47.
38. Gokce N, Duffy SJ, Hunter LM, Keaney JF, Vita JA. Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults. Am J Cardiol 2001; 88: 153-9.
39. Bae JH, Bassenge E, Kim KB et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 2001; 155: 517-23.
40. Lamarche B, Tchernof A, Moorjani S et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69-75.
41. Griffin BA, Freeman DJ, Tait GW et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241-53.
42. Kondo A, Muranaka Y, Ohta I et al. Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL. Clin Chem 2001; 47: 893-900.
43. Miller M. Differentiating the effects of raising low levels of high-density lipoprotein cholesterol versus lowering normal triglycerides: further insights from the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 2000; 86 (Suppl.) : 23L-27L.
44. Lamarche B, Rashid S, Lewis GF. HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 1999; 286: 145-61.
45. Watts GF. Postprandial lipaemia in familial hypercholesterolaemia: clinical and metabolic significance. Atherosclerosis 2000; 148: 426-8.
46. Wiegman A, Rodenburg J, de Jongh S et al. Family history and cardiovascular risk in familial hypercholesterolemia. Data in more than 1000 children. Circulation 2003; 107: 1473-8.
47. Kolovou G, Daskalova D, Anagnostopoulou K et al. Postprandial hypertriglyceridaemia in patients with Tangier Disease. J Clin Pathol 2003; 56: 937-41.
48. Mikhailidis DP, Papadakis JA, Ganotakis ES. Smoking, diabetes and hyperlipidaemia. J R Soc Health 1998; 118: 91-3.
49. Cohn JS. Postprandial lipid metabolism. Curr Opin Lipidol 1994; 5: 185-90.
50. Dane-Stewart CA, Watts GF, Mamo JC, Dimmitt SB, Barrett PH, Redgrave TG. Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia. Eur J Clin Invest 2001; 31: 113-7.
51. Wierzbicki AS, Mikhailidis DP, Wray R et al. Statin-fibrate combination: therapy for hyperlipidemia: a review. Curr Med Res Opin 2003; 19: 155-68.
52. Twickler TB, Dallinga-Thie GM, de Valk HW et al. High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000; 20: 2422-7.